Market Overview

Recent Stories

Celgene Corporation (NASDAQ: CELG) stock plummeted 10 percent Friday after the company reported that its testing of GED-0301 for treatment of Crohn’s disease has failed to meet its efficacy targets.

Groupon Inc (NASDAQ: GRPN) shares are trading lower by 25 cents (4.8 percent) at $4.70 in Friday's session.

Off the opening bell, the stock was under selling pressure based on a rumor that the company had cancelled a presentation at Credit Suisse's Tech Media Telecom Conference.

Baird Equity Research maintains an Outperform rating for athenahealth, Inc (NASDAQ: ATHN) after the company reported earnings Thursday after the market close.

Following its meeting with the FDA and the EMA, Uniqure NV (NASDAQ: QURE) announced it would expeditiously advance its adeno-associated virus, or AAV-based gene therapy, AMT-061 into pivotal trials in severe and moderately severe hemophilia B.

The earnings parade continues with Caterpillar Inc. (NYSE: CAT) and Eli Lilly & Co (NYSE: LLY) scheduled to report early next week. Both companies are expected to release results before market open on Tuesday, October 24.

Yet another earnings miss and guidance cut and the threat of a potential dividend reduction may have given General Electric Company (NYSE: GE) traders exactly what they’ve been waiting for: rock bottom.

Following the release of fiscal year first-quarter results by Atlassian Corporation PLC (NASDAQ: TEAM), Canaccord Genuity said the results were solid.

If you’ve followed my trading at all, or have read my blog, you know that I love trading momentum stocks. One of my favorite strategies is catching stocks as they break out on high volume, getting in quickly, and exiting for a profit just before the momentum ends.

Latium, a tasking platform that blends an artificial intelligence-based user reputation score with a “one-to-many” task relationship structure, has announced will launch a token sale of its Latium LATX cryptocurrency on Nov. 15, in a limited offering.

SunTrust Banks, Inc.'s STI third-quarter 2017 earnings of $1.06 per share were in line the Zacks Consensus Estimate. Also, the figure was up 16% year over year.